nodes	percent_of_prediction	percent_of_DWPC	metapath
Trisalicylate-choline—PTGS2—periodontitis	0.983	1	CbGaD
Trisalicylate-choline—PTGS2—periosteum—periodontitis	0.00398	0.34	CbGeAlD
Trisalicylate-choline—Magnesium salicylate—PTGS2—periodontitis	0.00237	0.54	CrCbGaD
Trisalicylate-choline—Salsalate—PTGS2—periodontitis	0.00201	0.46	CrCbGaD
Trisalicylate-choline—PTGS1—endothelium—periodontitis	0.00154	0.131	CbGeAlD
Trisalicylate-choline—PTGS2—endothelium—periodontitis	0.00147	0.125	CbGeAlD
Trisalicylate-choline—PTGS2—mouth—periodontitis	0.00113	0.0966	CbGeAlD
Trisalicylate-choline—PTGS2—trigeminal ganglion—periodontitis	0.000837	0.0713	CbGeAlD
Trisalicylate-choline—PTGS1—connective tissue—periodontitis	0.000727	0.0619	CbGeAlD
Trisalicylate-choline—PTGS2—connective tissue—periodontitis	0.000694	0.0592	CbGeAlD
Trisalicylate-choline—PTGS1—epithelium—periodontitis	0.00069	0.0588	CbGeAlD
Trisalicylate-choline—PTGS2—epithelium—periodontitis	0.000659	0.0562	CbGeAlD
Trisalicylate-choline—PTGS1—Eicosanoid Synthesis—GGT1—periodontitis	4.12e-05	0.0486	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—SLC52A3—periodontitis	3.56e-05	0.042	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Overview of nanoparticle effects—CRP—periodontitis	3.45e-05	0.0407	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Eicosanoid Synthesis—GGT1—periodontitis	3.27e-05	0.0386	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—MMP1—periodontitis	3.17e-05	0.0375	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—periodontitis	2.95e-05	0.0348	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Overview of nanoparticle effects—CRP—periodontitis	2.74e-05	0.0323	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Overview of nanoparticle effects—PTGS2—periodontitis	2.31e-05	0.0273	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Arachidonic acid metabolism—GGT1—periodontitis	2.29e-05	0.027	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL4—periodontitis	2.26e-05	0.0267	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Overview of nanoparticle effects—CXCL8—periodontitis	2.24e-05	0.0265	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—ACP5—periodontitis	2.1e-05	0.0248	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—MPO—periodontitis	1.92e-05	0.0227	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Eicosanoid Synthesis—PTGS2—periodontitis	1.92e-05	0.0226	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Arachidonic acid metabolism—GGT1—periodontitis	1.82e-05	0.0215	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Overview of nanoparticle effects—CXCL8—periodontitis	1.78e-05	0.021	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—periodontitis	1.6e-05	0.0189	CbGpPWpGaD
Trisalicylate-choline—PTGS2—C-MYB transcription factor network—MPO—periodontitis	1.58e-05	0.0187	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Overview of nanoparticle effects—TNF—periodontitis	1.56e-05	0.0184	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Signaling mediated by p38-alpha and p38-beta—NOS2—periodontitis	1.53e-05	0.0181	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—MPO—periodontitis	1.53e-05	0.018	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—periodontitis	1.46e-05	0.0172	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—GGT1—periodontitis	1.46e-05	0.0172	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—periodontitis	1.36e-05	0.0161	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Overview of nanoparticle effects—IL6—periodontitis	1.26e-05	0.0149	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Overview of nanoparticle effects—TNF—periodontitis	1.24e-05	0.0146	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—FCGR2A—periodontitis	1.22e-05	0.0144	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—GGT1—periodontitis	1.16e-05	0.0137	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Arachidonic acid metabolism—PTGS2—periodontitis	1.07e-05	0.0126	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—CCR2—periodontitis	1.06e-05	0.0125	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—CRP—periodontitis	1.01e-05	0.0119	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Overview of nanoparticle effects—IL6—periodontitis	9.99e-06	0.0118	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—periodontitis	8.82e-06	0.0104	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Biological oxidations—GGT1—periodontitis	8.52e-06	0.0101	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—CCL2—periodontitis	8.32e-06	0.00982	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—periodontitis	8.2e-06	0.00969	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—CRP—periodontitis	8.03e-06	0.00948	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—IL1A—periodontitis	7.59e-06	0.00897	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—IL4—periodontitis	7.34e-06	0.00867	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—IFNG—periodontitis	7.07e-06	0.00835	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—PTGS2—periodontitis	6.78e-06	0.00801	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—CCL2—periodontitis	6.6e-06	0.0078	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—IL1B—periodontitis	6.31e-06	0.00745	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Aryl Hydrocarbon Receptor—TNF—periodontitis	6.1e-06	0.00721	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—TLR4—periodontitis	6.08e-06	0.00719	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—NTRK1—periodontitis	5.87e-06	0.00694	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—NOS2—periodontitis	5.79e-06	0.00684	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—periodontitis	5.71e-06	0.00674	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—IFNG—periodontitis	5.61e-06	0.00663	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—CCL2—periodontitis	5.22e-06	0.00617	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—IL1B—periodontitis	5.01e-06	0.00591	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—TNF—periodontitis	4.58e-06	0.0054	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—SLC52A3—periodontitis	4.45e-06	0.00525	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—IFNG—periodontitis	4.44e-06	0.00524	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—SLC52A3—periodontitis	4.21e-06	0.00498	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—CXCL8—periodontitis	4.13e-06	0.00487	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—IL1B—periodontitis	3.96e-06	0.00468	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—MMP9—periodontitis	3.73e-06	0.00441	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—IL6—periodontitis	3.69e-06	0.00436	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—TNF—periodontitis	3.63e-06	0.00429	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—SLC52A3—periodontitis	3.53e-06	0.00417	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—GGT1—periodontitis	3.27e-06	0.00386	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—FGF2—periodontitis	3.21e-06	0.00379	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—TGFB1—periodontitis	3.08e-06	0.00363	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—IL6—periodontitis	2.93e-06	0.00346	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—TNF—periodontitis	2.87e-06	0.00339	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—LTF—periodontitis	2.86e-06	0.00338	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ACP5—periodontitis	2.62e-06	0.00309	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—GGT1—periodontitis	2.6e-06	0.00307	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—ACP5—periodontitis	2.48e-06	0.00293	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—PPARA—periodontitis	2.34e-06	0.00277	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—IL6—periodontitis	2.32e-06	0.00274	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—periodontitis	2.09e-06	0.00247	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ACP5—periodontitis	2.08e-06	0.00246	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—periodontitis	1.95e-06	0.00231	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—PPARA—periodontitis	1.86e-06	0.0022	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—periodontitis	1.52e-06	0.0018	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—GGT1—periodontitis	1.46e-06	0.00172	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—GGT1—periodontitis	1.16e-06	0.00137	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PPARA—periodontitis	1.04e-06	0.00123	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—NOS2—periodontitis	8.74e-07	0.00103	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PPARA—periodontitis	8.28e-07	0.000978	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—FGF2—periodontitis	7.13e-07	0.000842	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PTGS2—periodontitis	6.78e-07	0.000801	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—TGFB1—periodontitis	4.65e-07	0.000549	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—IL6—periodontitis	3.5e-07	0.000414	CbGpPWpGaD
